VibroSense Dynamics AB is a corporate office located in Malmö that specializes in innovative technology aimed at the early detection of nerve damage. The company has developed the VibroSense Meter® II, which is designed to protect patients by identifying sensory neuropathy, particularly in the hands and feet. This technology has applications in various medical fields, including cancer treatment and diabetes management, and is recognized as a new standard for reliable nerve damage detection.
The organization is committed to enhancing patient care and outcomes through its advanced medical diagnostics. VibroSense Dynamics AB places a strong emphasis on research and development, striving to contribute to groundbreaking advancements in the field of medical technology. The company also provides updates and press releases to keep stakeholders informed about its activities and developments. Recently, it has noted delays in product deliveries to China, which may affect its operations in that region.